Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

rapamycin (aka sirolimus), oral

Source date not recordedAnalyse record ↗

Often cited as the available molecule with the broadest & most consistent evidence of meaningful benefit for aging. Viewed by some as a CR mimetic.

Modality
drug
Availability (US)
by prescription
Biomarkers
?
Hallmark targeted
mTOR
Kind
age slowing
Lifespan.io link
detailed page, Feb 2024
Gerotherapeutics score
9
Rodent lifespan
+225 days (+43%)
Other papers
2024 PEARL trial preprint; many others [good review needed]
Clinical trials
thousands (many not for aging, eg for immune supression)
Tested by ITP
yes
ITP year first tested
2005
ITP median % ↑ (♂, best cohort)
22.00
ITP median % ↑ (♀, best cohort)
28.00
ITP P90 % ↑ (♂, best cohort)
11.00
ITP P90 % ↑ (♀, best cohort)
21.00
ITP sex effect
both
ITP dose (ppm)
14 ppm; 4.7 ppm; 42 ppm
ITP age at start (mo)
20 mo; 9 mo; 20 mo (stop at 23)
ITP replicated
yes
ITP result status
Legacy detailed stats + official summary cross-check; Published (full stats)

ITP cohort detail (7)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2005C200514 ppm20%13%9%14%↗ paper
2006C200614 ppm8%17%11%16%↗ paper
2009C200914 ppm10%22%8%21%↗ paper
2009C20094.7 ppm3%17%6%14%↗ paper
2009C200942 ppm22%28%8%20%↗ paper
2015C201542 ppm11%4%5%4%↗ paper
2015C201542 ppm11%15%9%12%↗ paper